BioCentury
ARTICLE | Company News

Centegen, sanofi-aventis deal

January 17, 2011 8:00 AM UTC

sanofi-aventis' animal health subsidiary Merial Ltd. received an exclusive, worldwide license to develop and commercialize Centegen's CEN-102 vaccine against Staphylococcus aureus infections for veter...